MYCN and neuroblastoma: These data suggest that increased global HDAC expression may occur independently of MYCN-mediated effects, and in vitro assessment of H3 histone acetylation validated that M344 treatment increases histone acetylation in both MYCN-amplified and non-amplified NB cell lines (Figure 2).